Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 3/20 | 0.39 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | NPY1R | P25929 | 1/20 | 0.36 |
| ▸ | NPY2R | P49146 | 1/20 | 0.36 |
| ▸ | NPY4R | P50391 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31514358 | 0.95 | MME (0.44) | MMEBACE1PTPN1 | |
| SCHEMBL30254481 | 0.94 | MME (0.42) | MMEOPRM1OPRD1BACE1NPY1R | |
| SCHEMBL30781148 | 0.94 | MME (0.37) | MMEOPRM1OPRD1OPRK1 | |
| SCHEMBL30973978 | 0.93 | OPRM1 (0.42) | MMEOPRM1OPRD1OPRK1LTA4H | |
| SCHEMBL30426633 | 0.92 | OPRD1 (0.35) | MMEOPRM1OPRD1OPRK1BACE1 | |
| SCHEMBL29531532 | 0.92 | MME (0.41) | MMELTA4H | |
| SCHEMBL30728878 | 0.91 | MME (0.43) | MMENPY1RNPY2RNPY4RLTA4H | |
| SCHEMBL29557496 | 0.90 | BACE1 (0.38) | MMEOPRM1OPRD1OPRK1BACE1 | |
| SCHEMBL29442611 | 0.89 | MME (0.41) | MMEOPRM1OPRD1OPRK1NPY1R | |
| SCHEMBL1666827 | 0.88 | MME (0.44) | MMELTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118871126-A | Tumor antigen and compound containing tumor antigen TRAS, TPX2 or AURKA and application thereof | 勃林格殷格翰国际有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-109963585-B | Fusion for treating cancer comprising a cell penetrating peptide, a polyepitope and a TLR peptide agonist | 阿尔勒治疗公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-116723853-A | Combination of STING agonist and complex comprising cell penetrating peptide, cargo and TLR peptide agonist | 勃林格殷格翰国际有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-116348137-A | Heterologous prime boost vaccine | 勃林格殷格翰国际有限公司 | 2023-06-27 | — | — | CN | disclosed |